Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation

Biomaterials

Volumn 24, Issue 19, 2003, Pages 3229-3234

  Bosserhoff, Anja K ^a   Buettner, Reinhard ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

CD RAP; Chondrocyte; Differentiation; MIA; Tissue engineering

Indexed keywords

BIOMARKERS; CARTILAGE; DISEASES; PATHOLOGY; PHYSIOLOGY;

TISSUE ENGINEERING;

PROTEINS;

BIOLOGICAL MARKER; CARTILAGE DERIVED RETINOIC ACID SENSITIVE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROPATHY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA INHIBITORY ACTIVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; TISSUE CULTURE; TISSUE ENGINEERING;

EID: 0038634560     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00184-4     Document Type: Article

References (13)

1. Blesch A., Bosserhoff A.K., Apfel R., Behl C., Hessdörfer B., Schmitt A., Jachimczak P., Lottspeich F., Schlingensiepen H., Buettner R., Bogdahn U. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA. Cancer Res. 54:1994;5695-5701.
2. Bosserhoff A.K., Kondo S., Moser M., Dietz U.H., Copeland N.G., Gilbert D.J. Mouse CD-RAP/MIA Gene. structure, chromosomal localization, and expression in cartilage and chondrosarcoma Dev Dyn. 208:1997;516-525.
3. Bosserhoff A.K., Moser M., Hein R., Landthaler M., Buettner R. In situ expression patterns of melanoma-inhibiting activity (MIA) in malignant melanomas and breast cancers. J Pathol. 187:1999;446-454.
4. Dietz U.H., Sandell L.J. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem. 271:1996;3311-3316.
5. Sakano S., Zhu Y., Sandell L.J. Cartilage-derived retinoic acid-sensitive protein and type II collagen expression during fracture healing are potential targets for Sox9 regulation. J Bone Miner Res. 14:1999;1891-1901.
6. Neame P.J., Tapp H., Azizan A. Noncollagenous, nonproteoglycan macromolecules of cartilage. Cell Mol Life Sci. 55:1999;1327-1340.
7. Xie W.F., Kondo S., Sandell L.J. Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2. J Biol Chem. 273:1998;5026-5032.
8. Stoll R., Renner C., Ambrosius D., Golob M., Breibach I., Voelter W., Buettner R., Holak T.A., Bosserhoff A.K. Structure and dynamics of human melanoma inhibitory activity (MIA) protein in solution. implications for metastasis EMBO. 20:2001;340-349.
9. Bosserhoff A.K., Kaufmann M., Kaluza B., Bartke I., Zirngibl H., Hein R., Stolz W., Buettner R. MIA, a novel serum marker for progression of malignant melanoma. Cancer Res. 57:1997;3149-3153.
10. Neidhart M., Müller-Ladner U., Frey W., Bosserhoff A.K., Colombani P.C., Frey-Rindova P. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage. 8:2000;222-229.
11. Müller-Ladner U., Bosserhoff A.K., Dreher K., Hein R., Neidhart M., Gay S. MIA (melanoma inhibitory activity). a potential serum marker for rheumatoid arthritis Rheumatology. 38:1999;148-154.
12. Moser M., Bosserhoff A.K., Hunziker E.B., Sandell L., Fässler R., Buettner R. Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol. 22:2002;1438-1445.
13. Eyre D.R. Collagens of articular cartilage. Arthritis Res. 4:2002;30-35.